Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference136 articles.
1. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein;Thomas;Cancer Control,2003
2. P-glycoprotein: from genomics to mechanism;Ambudkar;Oncogene,2003
3. Overcoming multidrug resistance in cancer stem cells;Moitra;BioMed Res Int.,2015
4. Molecular mechanisms for tumour resistance to chemotherapy;Pan;Clin Exp Pharmacol Physiol,2016
5. Biochemical, cellular, and pharmacological aspects of the multidrug transporter;Ambudkar;Annu Rev Pharmacol Toxicol,1999
Cited by 79 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Not dead yet: cell death and survival in cancer and normal physiology;Frontiers in Cell Death;2024-09-11
2. Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies;Cancers;2024-08-16
3. Advancements in dendrimer-based drug delivery for combinatorial cancer therapy;Journal of Drug Delivery Science and Technology;2024-08
4. A study with cancer stem cells and three-dimensional tumoroids: investigation of the combined effects of 5-fluorouracil and doxorubicin in breast cancer;Medical Oncology;2024-06-23
5. KHDRBS3 facilitates self-renewal and temozolomide resistance of glioblastoma cell lines;2024-06-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3